Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine
These two studies were aimed to evaluate the efficacy of ERAVAC® in naïve rabbits up to 6 months after immunization, although protection for a longer period of time (up to 12 month) as an aid to establish the most adequate prevention program for the disease was also explored.
This study demonstrates the following: • RHDV-2 vaccine stimulates the humoral response at 7 dpv, inducing high and long lasting antibody titers up to 12 mpv. • RHDV-2 vaccine confers protective immunity to virulent heterologous challenge. • A RHDV-2 prevention program could be based on a vaccination interval of at least 12 months.